巴曲酶联合阿司匹林对下肢骨折伴深静脉血栓患者急性期凝血功能、炎症反应及症状的影响
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

广东省佛山市卫生健康局医学科研项目(20220463);


Effect of baclofen combined with aspirin on coagulation function,inflam-matory response,and symptoms in patients with lower limb fractures ac-companied by deep vein thrombosis during the acute phase
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
    摘要:

    目的:探讨巴曲酶注射液联合阿司匹林肠溶片对下肢骨折并发深静脉血栓患者急性期凝血功能、炎症反应及症状影响。方法:选取108例下肢骨折并发深静脉血栓患者为研究对象,根据治疗方案不同分为对照组和观察组,每组各54例。对照组患者采用阿司匹林肠溶片治疗;观察组患者在对照组基础上联合巴曲酶注射液治疗,持续治疗7 d后,两组患者均采用阿司匹林肠溶片继续治疗7个月以巩固疗效。治疗7 d后,比较两组患者疗效、凝血功能、血液流变学、炎症、静脉血流速度、下肢周径、疼痛[视觉疼痛模拟(VAS)评分]、下肢症状及不良反应发生情况。结果:观察组患者治疗有效率高于对照组(92.59%vs.77.78%,P<0.05)。治疗7 d后,观察组患者活化部分凝血酶时间(APTT)高于对照组(P<0.05);纤维蛋白原(FIB)、凝血酶原时间(PT)、全血高切黏度及全血低切黏度水平低于对照组(P<0.05);超敏C反应蛋白(hs-CRP)、降钙素原(PCT)、白细胞介素6(IL-6)水平低于对照组(P<0.05);静脉血流速度高于对照组(P<0.05);下肢周径、VAS评分、下肢肿胀、肤色及条索状或结节评分低于对照组(P<0.05)。两组患者不良反应发生率比较,差异无统计学意义(P>0.05)。结论:对于下肢骨折后发生下肢深静脉血栓患者,采用巴曲酶注射液联合阿司匹林肠溶片治疗的短期疗效确切,有利于改善急性期凝血功能及血液流变学指标水平,降低患者炎症及疼痛水平,改善下肢症状,值得临床推广应用。

    Abstract:

    Objective:To explore the effects of batroxobin injection combined with enteric-coated aspirin on coagulation func-tion,inflammatory response,and symptoms in patients with deep vein thrombosis following lower limb fractures during the acute phase.Methods:A total of 108 patients with lower limb fractures complicated by deep vein thrombosis were divided into a control group and an observation group according to different treatment methods,with 54 cases in each group.The control group received treatment with enter-ic-coated aspirin,while the observation group received batroxobin injection in addition to aspirin treatment,lasting for 7 days.Both groups continued treatment with enteric-coated aspirin for 7 months to consolidate the therapeutic effect.After 7 days of treatment,the efficacy,coagulation function,blood rheology,inflammation,venous blood flow velocity,lower limb circumference,pain[Visual Analog Scale(VAS)],lower limb symptoms,and incidence of adverse reactions were recorded and compared between the two groups.Results:The effective rate of treatment in the observation group was higher than that in the control group(92.59%vs.77.78%,P<0.05).Af-ter treatment,the activated partial thromboplastin time(APTT)in the observation group was higher than that in the control group(P<0.05),while fibrinogen(FIB),prothrombin time(PT),whole blood high shear viscosity,and whole blood low shear viscosity levels were all lower than those in the control group(P<0.05).Additionally,levels of hypersensitive C-reactive protein(hs-CRP),procalci-tonin(PCT),and interleukin-6(IL-6)in the observation group were lower than those in the control group(P<0.05).The venous blood flow velocity in the observation group was higher than that in the control group(P<0.05),and the lower limb circumference,VAS score,lower limb swelling,skin color,and cord-like or nodular scoring were all lower than those in the control group(P<0.05).There was no statistically significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion:For pa-tients with deep vein thrombosis following lower limb fractures,the short-term efficacy of batroxobin injection combined with enteric-coated aspirin is significant,beneficial for improving coagulation function and blood rheology indicators during the acute phase,and helps reduce inflammation and pain levels,effectively improving lower limb symptoms.It is worthy of clinical promotion and application.

    参考文献
    相似文献
    引证文献
引用本文

韩新峰;霍景山;杨志林;.巴曲酶联合阿司匹林对下肢骨折伴深静脉血栓患者急性期凝血功能、炎症反应及症状的影响[J].川北医学院学报,2025,40(6):782-786.

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-07-09
  • 出版日期:
文章二维码